Prelude Therapeutics
(NASDAQ) PRLD
Prelude Therapeutics Financials at a Glance
Market Cap
$217.99M
Revenue (TTM)
$12.14M
Net Income (TTM)
$99.50M
EPS (TTM)
$-1.35
P/E Ratio
-2.56
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$3.52
Volume
4,389
Open
$3.49
Price
$3.52
Volume
4,389
Open
$3.49
Previous Close
$3.52
Daily Range
$3.43 - $3.64
52-Week Range
$0.61 - $4.22
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$3.52
Volume
4,389
Open
$3.49
Previous Close
$3.52
Daily Range
$3.43 - $3.64
52-Week Range
$0.61 - $4.22
PRLD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Prelude Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
79
CEO
Krishna Vaddi, PhD
Website
www.preludetx.comHeadquarters
Wilmington, DE 19803, US
PRLD Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-9%
Net Income Margin
-8%
Return on Equity
-99%
Return on Capital
-1%
Return on Assets
-70%
Earnings Yield
-39.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$217.99M
Shares Outstanding
63.00M
Volume
4.39K
Short Interest
0.00%
Avg. Volume
343.60K
Financials (TTM)
Gross Profit
$10.43M
Operating Income
$104.57M
EBITDA
$102.86M
Operating Cash Flow
$56.30M
Capital Expenditure
$67.00K
Free Cash Flow
$56.37M
Cash & ST Invst.
$103.21M
Total Debt
$17.79M
Prelude Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.64M
+41.0%
Gross Profit
$5.22M
+30.6%
Gross Margin
92.59%
N/A
Market Cap
$217.99M
N/A
Market Cap/Employee
$1.66M
N/A
Employees
131
N/A
Net Income
$16.46M
+42.7%
EBITDA
$16.93M
+49.2%
Quarterly Fundamentals
Net Cash
$85.42M
-26.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.04M
-1.8%
Short Term Debt
$2.74M
+1.6%
Return on Assets
-70.41%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
$23.12M
+211.2%
Operating Cash Flow
$23.12M
+211.4%